Award recordCONTRACT

ONEBLOOD, INC

PIID 36C24826N0249· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2026· $662,280 net obligations· UEI SX3XGHRJMNQ5· FL

Description

WHOLE BLOOD DEOB OF FUNDS

Base award description: WHOLE BLOOD (2-MO EXTENSION)

First action · last action
2025-12-31 · 2026-06-15
Transactions
2
First transaction's obligation
$845,022
Base + all options value (sum of deltas)
$662,280
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24825D0048
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$845,022$0Base award · 2025-12-31 · this action $845,022 · running total $845,022Modification P00001 · 2026-06-15 · this action -$182,742 · running total $662,280
  • Base2025-12-31+$845,022= $845,022
  • Mod P000012026-06-15-$182,742= $662,280
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-12-31+$845,022$845,022WHOLE BLOOD (2-MO EXTENSION)
Mod P00001· FUNDING ONLY ACTION2026-06-15−$182,742$662,280WHOLE BLOOD DEOB OF FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)

AwardOffice · PSC / listingNet obligationsFY
36C24826N0419248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$792,973FY2026
36C24826N0424248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$268,659FY2026
36C24826N0399248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS$354,763FY2026
36C24826N0400248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$314,881FY2026
36C24826N0347248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$619,287FY2026
36C24826D0015248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$0FY2026

Other recipients under 6550 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826N0554AGILENT TECHNOLOGIES INC248-NETWORK CONTRACT OFFICE 8 (36C248)$35,634FY2026
36C24826N0393SYSMEX AMERICA, INC248-NETWORK CONTRACT OFFICE 8 (36C248)$340,032FY2026
36C24826N0602GOVERNMENT SCIENTIFIC SOURCE INC248-NETWORK CONTRACT OFFICE 8 (36C248)$579,998FY2026
36C24826N0392ABBOTT LABORATORIES INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$965,388FY2026
36C24826A0019GOVERNMENT SCIENTIFIC SOURCE INC248-NETWORK CONTRACT OFFICE 8 (36C248)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24826N0249_3600_36C24825D0048_3600 · retrieved 2026-09-26.